|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
|
EP2948544A4
(en)
|
2013-01-28 |
2016-08-03 |
St Jude Childrens Res Hospital |
CHIMERIC RECEPTOR WITH NKG2D SPECIFICITY FOR CELL THERAPY AGAINST CANCER AND INFECTION DISEASES
|
|
WO2015105955A1
(en)
|
2014-01-08 |
2015-07-16 |
Flodesign Sonics, Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
|
DK3143134T3
(da)
|
2014-05-15 |
2021-01-04 |
Nat Univ Singapore |
Modificerede, naturlige dræberceller og anvendelser deraf
|
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
|
EP3184548A1
(en)
*
|
2015-12-23 |
2017-06-28 |
Miltenyi Biotec GmbH |
Chimeric antigen receptor with cytokine receptor activating or blocking domain
|
|
CN109715808A
(zh)
*
|
2016-04-15 |
2019-05-03 |
诺华股份有限公司 |
用于选择性蛋白质表达的组合物和方法
|
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
|
CN117959418A
(zh)
*
|
2017-03-13 |
2024-05-03 |
波赛达治疗公司 |
用于选择性消除和替换造血干细胞的组合物和方法
|
|
BR112019019917A2
(pt)
|
2017-03-27 |
2020-04-22 |
Nat Univ Singapore |
receptores quiméricos nkg2d truncados e seus usos em imunoterapia de células exterminadoras naturais
|
|
CA3056591A1
(en)
|
2017-03-27 |
2018-10-04 |
National University Of Singapore |
Stimulatory cell lines for ex vivo expansion and activation of natural killer cells
|
|
BR102018006205A2
(pt)
*
|
2017-03-28 |
2021-03-23 |
Cell Design Labs, Inc. |
Polipeptídeos quiméricos e métodos de alterar a localização da membrana dos mesmos
|
|
CA3059542A1
(en)
*
|
2017-04-12 |
2018-10-18 |
Pfizer Inc. |
Antibodies having conditional affinity and methods of use thereof
|
|
US11939379B2
(en)
*
|
2017-05-19 |
2024-03-26 |
The Regents Of The University Of California |
Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies
|
|
US20230159611A1
(en)
*
|
2017-07-03 |
2023-05-25 |
Yale University |
Small molecule adapter regulated, target specific chimeric antigen receptor bearing t cells (smart cars)
|
|
CN107312797B
(zh)
*
|
2017-07-28 |
2021-06-18 |
广州中科蓝华生物科技有限公司 |
一种蛋白调控系统及其制备方法和应用
|
|
KR20260026092A
(ko)
|
2017-09-19 |
2026-02-25 |
메사추세츠 인스티튜트 오브 테크놀로지 |
키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도
|
|
AU2018351050B2
(en)
|
2017-10-18 |
2025-09-18 |
Novartis Ag |
Compositions and methods for selective protein degradation
|
|
KR102439221B1
(ko)
|
2017-12-14 |
2022-09-01 |
프로디자인 소닉스, 인크. |
음향 트랜스듀서 구동기 및 제어기
|
|
CA3084551A1
(en)
|
2017-12-14 |
2019-06-20 |
Bluebird Bio, Inc. |
Daric interleukin receptors
|
|
SG11202005307RA
(en)
*
|
2017-12-14 |
2020-07-29 |
Bluebird Bio Inc |
Nkg2d daric receptors
|
|
EP3502130A1
(en)
|
2017-12-20 |
2019-06-26 |
St. Anna Kinderkrebsforschung |
Ligand regulated protein-protein interaction system
|
|
CN118206634A
(zh)
|
2017-12-20 |
2024-06-18 |
圣安娜儿童癌症研究中心 |
配体调控的蛋白-蛋白相互作用系统
|
|
EP3749685A4
(en)
|
2018-02-09 |
2021-12-22 |
National University of Singapore |
ACTIVATOR CHEMERIC RECEPTORS AND THEIR USES IN NATURAL KILLING CELL IMMUNOTHERAPY
|
|
CN111094358A
(zh)
|
2018-02-11 |
2020-05-01 |
江苏恒瑞医药股份有限公司 |
一种分离的嵌合抗原受体以及包含其的修饰t细胞及用途
|
|
JP7334985B2
(ja)
|
2018-04-02 |
2023-08-29 |
ナショナル ユニヴァーシティー オブ シンガポール |
免疫細胞で発現される膜結合抗サイトカイン非シグナル伝達バインダーによるヒトサイトカインの中和
|
|
MX2020011254A
(es)
*
|
2018-04-27 |
2020-11-12 |
Crispr Therapeutics Ag |
Celulas t car anti-bcma para agotamiento de celulas de plasma.
|
|
GB201813178D0
(en)
*
|
2018-08-13 |
2018-09-26 |
Autolus Ltd |
Cell
|
|
EP3844186A4
(en)
|
2018-08-29 |
2022-08-17 |
National University of Singapore |
METHOD OF SPECIFIC STIMULATION OF SURVIVAL AND EXPANSION OF GENETICALLY MODIFIED IMMUNE CELLS
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
EP4588483A3
(en)
*
|
2018-10-03 |
2025-09-24 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Covalent adaptor synnotch and chimeric antigen receptors (cars) for programmable antigen-targeting
|
|
WO2020070290A1
(en)
|
2018-10-05 |
2020-04-09 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
EP3632461A1
(en)
|
2018-10-05 |
2020-04-08 |
St. Anna Kinderkrebsforschung |
A group of chimeric antigen receptors (cars)
|
|
CA3120563A1
(en)
|
2018-11-26 |
2020-06-04 |
Nkarta, Inc. |
Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy
|
|
KR20210104772A
(ko)
|
2018-12-14 |
2021-08-25 |
블루버드 바이오, 인코포레이티드. |
이량체화제로 조절된 면역수용체 복합체
|
|
BR112021013173A2
(pt)
*
|
2019-01-04 |
2021-09-28 |
The University Of Chicago |
Sistemas e métodos para modular rna
|
|
EP3773918A4
(en)
|
2019-03-05 |
2022-01-05 |
Nkarta, Inc. |
CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY
|
|
BR112021020999A2
(pt)
|
2019-05-04 |
2021-12-14 |
Inhibrx Inc |
Polipeptídeos de ligação à clec12a e usos dos mesmos
|
|
JP2022532868A
(ja)
|
2019-05-04 |
2022-07-20 |
インヒブルクス インコーポレイテッド |
Ｃｄ１２３結合性ポリペプチド及びその使用
|
|
CN114040927A
(zh)
|
2019-05-04 |
2022-02-11 |
印希比股份有限公司 |
结合cd33的多肽及其用途
|
|
US12552855B2
(en)
*
|
2019-05-08 |
2026-02-17 |
Regeneron Pharmaceuticals, Inc. |
CD33 targeted immunotherapies
|
|
MA55910A
(fr)
*
|
2019-05-08 |
2022-03-16 |
2Seventy Bio Inc |
Immunothérapies ciblant cd123
|
|
KR20220031549A
(ko)
*
|
2019-05-08 |
2022-03-11 |
2세븐티 바이오, 인코포레이티드 |
Cll-1 표적화 면역요법
|
|
WO2020263399A1
(en)
|
2019-06-26 |
2020-12-30 |
Massachusetts Institute Of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
WO2021061648A1
(en)
|
2019-09-23 |
2021-04-01 |
Massachusetts Institute Of Technology |
Methods and compositions for stimulation of endogenous t cell responses
|
|
JP2022551820A
(ja)
*
|
2019-10-15 |
2022-12-14 |
エフ．ホフマン－ラ ロシュ アーゲー |
細胞内または小胞内生体分子相互作用を検出するための人工膜貫通タンパク質
|
|
WO2021087183A1
(en)
*
|
2019-10-31 |
2021-05-06 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for chimeric antigen receptor targeting cancer cells
|
|
CA3164226A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Cilag Gmbh International |
Multispecific binding molecules comprising ltbr and edb binding domains and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
JP2023530182A
(ja)
*
|
2020-06-22 |
2023-07-13 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
多重サブユニットタンパク質モジュール、それを発現する細胞、及びその使用
|
|
US12144827B2
(en)
|
2021-02-25 |
2024-11-19 |
Lyell Immunopharma, Inc. |
ROR1 targeting chimeric antigen receptor
|
|
US20260083848A1
(en)
|
2021-11-03 |
2026-03-26 |
Viracta Therapeutics, Inc. |
Combination of car t-cell therapy with btk inhibitors and methods of use thereof
|
|
CN120265319A
(zh)
*
|
2022-09-20 |
2025-07-04 |
丹娜-法伯癌症研究院 |
受体介导的胞吞作用用于膜蛋白和货物的靶向内化和降解
|
|
CN119638840A
(zh)
*
|
2023-09-15 |
2025-03-18 |
东莞市朋志生物科技有限公司 |
一种抗糖类抗原153的抗体及其应用
|